Disease risk prediction on Amyloid modality AD vs. CN
93.09Precision
RGCN+
Updated 1mo ago
Evaluation Results
| Method | Links | |||
|---|---|---|---|---|
2023.07 | 93.09 | 92.86 | 92.92 | |
2023.07 | 90.56 | 90.48 | 90.27 | |
2023.07 | 89.62 | 87.8 | 88.22 | |
2023.07 | 88.37 | 88.1 | 87.68 | |
2023.07 | 87.98 | 88.1 | 87.98 | |
2023.07 | 85.75 | 85.56 | 85.34 | |
2023.07 | 83.87 | 85.29 | 82.3 | |
2023.07 | 81.58 | 80.77 | 78.14 | |
2023.07 | 81.54 | 80.78 | 78.07 | |
2023.07 | 79.98 | 81.24 | 77.42 | |
2023.07 | 70.59 | 75.02 | 65.87 | |
2023.07 | 65.53 | 80.95 | 72.43 |